| Literature DB >> 15117970 |
Yuji Yamaguchi1, Satoshi Itami, Hidenori Watabe, Ken-Ichi Yasumoto, Zalfa A Abdel-Malek, Tateki Kubo, François Rouzaud, Atsushi Tanemura, Kunihiko Yoshikawa, Vincent J Hearing.
Abstract
We investigated whether or not the topographic regulation of melanocyte differentiation is determined by mesenchymal-epithelial interactions via fibroblast-derived factors. The melanocyte density in palmoplantar human skin (i.e., skin on the palms and the soles) is five times lower than that found in nonpalmoplantar sites. Palmoplantar fibroblasts significantly suppressed the growth and pigmentation of melanocytes compared with nonpalmoplantar fibroblasts. Using cDNA microarray analysis, fibroblasts derived from palmoplantar skin expressed high levels of dickkopf 1 (DKK1; an inhibitor of the canonical Wnt signaling pathway), whereas nonpalmoplantar fibroblasts expressed higher levels of DKK3. Transfection studies revealed that DKK1 decreased melanocyte function, probably through beta-catenin-mediated regulation of microphthalmia-associated transcription factor activity, which in turn modulates the growth and differentiation of melanocytes. Thus, our results provide a basis to explain why skin on the palms and the soles is generally hypopigmented compared with other areas of the body, and might explain why melanocytes stop migrating in the palmoplantar area during human embryogenesis.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15117970 PMCID: PMC2172049 DOI: 10.1083/jcb.200311122
Source DB: PubMed Journal: J Cell Biol ISSN: 0021-9525 Impact factor: 10.539
Figure 1.Melanocyte function in palmoplantar (PP) and in nonpalmoplantar (NP) skin. (A and B) Fontana-Masson staining for melanin. Bar, 100 μm. (C–N) Immunohistochemical staining for MITF (C and D), TYR (E and F), DCT (G and H), MART1 (I and J), and gp100 (K–N). HMB45 (K and L) and αPEP13h (M and N) specifically stain gp100 in stage II–IV melanosomes and in stage I melanosomes, respectively. Bar, 50 μm. (O) Melanocyte density measured by the number of cells positive for melanosomal proteins. Data are reported as means ± SD. (P) Macroscopic view of hypopigmented palm (palmoplantar) skin and hyperpigmented arm (nonpalmoplantar) skin.
Figure 2.Differential expression of leupaxin, DKK1, and DKK3 by palmoplantar (PP) and by nonpalmoplantar (NP) fibroblasts. Representative differences in gene expression patterns of leupaxin, DKK1, and DKK3 between palmoplantar fibroblasts and nonpalmoplantar fibroblasts as measured by microarray (top; quantitative results are summarized in Tables I and II). (middle) RT-PCR confirms the expression patterns of leupaxin, DKK1, and DKK3 in palmoplantar and in nonpalmoplantar fibroblasts. These data are representative of five independent experiments. (bottom) Real-time PCR to quantitate the expression of leupaxin, DKK1, and DKK3 after normalization of the target gene to GAPDH. Data are reported as means ± SD.
Genes highly expressed by palmoplantar fibroblasts detected by cDNA microarrays
| Fold difference | Accession no. | Gene name |
|---|---|---|
| 4.4 | NM_004811 | leupaxin |
| 3.6 | NM_012242 | dickkopf ( |
| 2.9 | NM_002730 | protein kinase, cAMP-dependent, catalytic, α |
| 2.8 |
| serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 2 |
| 2.7 | NM_002421 | matrix metalloproteinase 1 (interstitial collagenase) |
| 2.7 |
| ectonucleotide pyrophosphatase/phosphodiesterase 1 |
| 2.6 |
| caveolin 1, caveolae protein, 22 kD |
| 2.5 |
| serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1) |
| 2.5 |
| B-cell CLL/lymphoma 1 |
| 2.5 |
| Human mRNA for unknown product, partial cds |
| 2.5 |
| interleukin 13 receptor, α 2 |
| 2.3 |
| ribonucleotide reductase M1 polypeptide |
| 2.3 |
| SMC4 (structural maintenance of chromosomes 4, yeast)-like 1 |
| 2.2 | NM_004670 | 3′-phosphoadenosine 5′-phosphosulfate synthase 2 |
| 2.2 |
| RAB6 interacting, kinesin-like (rabkinesin6) |
| 2.1 | NM_001150 | alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, CD13, p150) |
| 2.1 |
| ESTs, highly similar to SMHU1B metallothionein 1B ( |
| 2.1 |
| metallothionein 1L |
| 2.1 | NM_000627 | latent transforming growth factor β binding protein 1 |
| 2.1 |
| Microfibril-associated glycoprotein 2 |
| 2 |
| minichromosome maintenance deficient ( |
| 2 | NM_002658 | plasminogen activator, urokinase |
| 2 |
| progesterone membrane binding protein |
| 2 | NM_006867 | RNA-binding protein gene with multiple splicing |
| 2 |
|
|
Genes highly expressed by nonpalmoplantar fibroblasts detected by cDNA microarrays
| Fold difference | Accession no. | Gene name |
|---|---|---|
| 3.6 | NM_005940 | matrix metalloproteinase 11 (stromelysin 3) |
| 2.4 |
| dickkopf ( |
| 2.4 |
| hexabrachion (tenascin C, cytotactin) |
| 2.2 | NM_001135 | aggrecan 1 (chondroitin sulfate proteoglycan 1) |
| 2.2 |
| stromal cell–derived factor 1 |
| 2.1 |
| serum/glucocorticoid-regulated kinase |
| 2.1 | NM_002188 | interleukin 13 |
| 2 |
| hepatocellular carcinoma–associated antigen 112 |
Effects of fibroblasts on melanocyte proliferation and differentiation in culture
| Palmoplantar fibroblasts
| Nonpalmoplantar fibroblasts
| |||||
|---|---|---|---|---|---|---|
| Untreated | Normal IgG | Anti-DKK1 IgG | Untreated | Normal IgG | Anti-DKK1 IgG | |
| Proliferation | 0.125 ± 0.007 | 0.128 ± 0.011 | 0.231 ± 0.034 | 0.192 ± 0.022 | 0.202 ± 0.011 | 0.200 ± 0.033 |
| vs. nonpalmoplantar | P < 0.001 | P < 0.001 | NS | — | — | — |
| vs. untreated | — | NS | P < 0.001 | — | NS | NS |
| TYR | 378 ± 15 | 319 ± 30 | 574 ± 53 | 812 ± 134 | 782 ± 145 | 793 ± 145 |
| vs. nonpalmoplantar | P < 0.05 | P < 0.05 | NS | — | — | — |
| vs. untreated | — | NS | P < 0.05 | — | NS | NS |
| Melanin | 137 ± 34 | 131 ± 26 | 249 ± 31 | 222 ± 24 | 203 ± 23 | 244 ± 5 |
| vs. nonpalmoplantar | P < 0.01 | P < 0.01 | NS | — | — | — |
| vs. untreated | — | NS | P < 0.001 | — | NS | NS |
Melanocytes were cocultured with palmoplantar or nonpalmoplantar fibroblasts for 5 d (in the presence or absence of normal or anti-DKK1 IgG, where noted) after which cell growth, TYR, and melanin were measured, as detailed in Materials and methods. Proliferation is reported as A562; TYR is reported as counts per minute per microgram of total protein per hour; and melanin is reported as nanogram of melanin per microgram of total protein. All experiments were repeated three times in duplicate. Data are reported as means ± SD.
Figure 3.DKK1 decreases the growth and pigmentation of melanocytes. To investigate the effects of DKK1 and 3 on melanocyte function, studies using melanocytes cocultured with transfected fibroblasts were performed. (A) Phase-contrast micrographs of melanocytes cocultured with control-, DKK1-, or DKK3-transfected fibroblasts. (B) Proliferation of melanocytes cocultured with fibroblasts transfected with control, DKK1, or DKK3 as measured by the MTT assay. (C) TYR activity in melanocytes cocultured with transfected fibroblasts as measured by the C14-tyrosine assay. (D) Melanin production by melanocytes cocultured with transfected fibroblasts as detected by the melanin assay. These data are representative results of five independent experiments. (B–D) +Ab indicates cocultures performed in the presence of DKK1-inhibitory antibody for 5 d. Data are reported as means ± SD.
Figure 4.Regulation of melanocyte function by fibroblasts expressing DKK1 or DKK3. (A) Immunohistochemistry of TYR (top, green) or MITF (bottom, red) expression by melanocytes cocultured with control-, DKK1-, or DKK3-transfected fibroblasts. (B) Western blotting to examine expression of melanogenic proteins; cell extracts obtained from melanocytes cocultured for 5 d with transfected fibroblasts. Expression of β-actin was used as a loading control. (C) Expression of MITF was analyzed in extracts of nuclei obtained from melanocytes after 5 d of coculture. β-actin is shown as a loading control. The numbers on the blots in B and C represent their quantitation as a percentage of control, corrected against the β-actin loading control. These data are representative results of four independent experiments.
Figure 5.MITF rescues DKK1-mediated changes in melanocyte function. Immunohistochemistry of MITF (red), TYR (green), DCT (green), and MART1 (red) expression by control vector–transfected melanocytes (top), DKK1-transfected melanocytes (middle), or DKK1- and MITF-cotransfected melanocytes (bottom); DAPI is shown in blue. Panels for MITF and TYR are from the same field, as are panels for DCT and MART1. Insets show higher magnifications of fields in the larger panels. This experiment was performed four times with similar results.
Figure 6.Regulation of cell signaling intermediates by DKK1. (A) Expression of β-catenin was analyzed by Western blot in cell extracts obtained from melanocytes cocultured for 5 d with control- or DKK1-transfected fibroblasts (left) or from melanocytes treated for 3 h with or without 50 ng/ml DKK1 (right). β-actin is shown as a loading control. The numbers below the bands represent their quantitation as a percentage of control, corrected against the β-actin loading control. This experiment was performed four times with melanocytes and fibroblasts derived from different individuals with similar results. (B) Immunohistochemical studies were performed using biopsy specimens of palmoplantar and nonpalmoplantar skin. The expression of β-catenin was examined (stained green), and melanocytes were detected by localization of MART1 (stained red). (C) Scheme illustrating the potential mechanism by which DKK1 decreases melanocyte growth and differentiation.